Related Experiment Video

Updated: Jun 20, 2026

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

Radiotherapy: IMRT reduces xerostomia and potentially improves QoL

Avraham Eisbruch

    Nature Reviews. Clinical Oncology
    |September 30, 2009
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Retroductal Submandibular Gland Instillation and Localized Fractionated Irradiation in a Rat Model of Salivary Hypofunction
    07:44

    Retroductal Submandibular Gland Instillation and Localized Fractionated Irradiation in a Rat Model of Salivary Hypofunction

    Published on: April 24, 2016

    Related Experiment Videos

    Last Updated: Jun 20, 2026

    Stereotactic Radiosurgery for Gynecologic Cancer
    10:35

    Stereotactic Radiosurgery for Gynecologic Cancer

    Published on: April 17, 2012

    Retroductal Submandibular Gland Instillation and Localized Fractionated Irradiation in a Rat Model of Salivary Hypofunction
    07:44

    Retroductal Submandibular Gland Instillation and Localized Fractionated Irradiation in a Rat Model of Salivary Hypofunction

    Published on: April 24, 2016

    Related Concept Videos

    Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

    Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

    5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
    Cancer Therapies02:49

    Cancer Therapies

    Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
    However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

    Articles linked to this work by shared authors, journal, and citation graph.

    Non-Metastatic Squamous Cell Carcinoma of the Oropharynx: Primary Surgery or (Chemo)radiotherapy?

    Head & neck·2026

    Reply to Borewad et al. Comment on "Rao et al. The Oncological Outcome of Postoperative Radiotherapy in Patients with Node-Negative Early-Stage (T1/T2/N0) Oral Squamous Cell Carcinoma and Perineural Invasion: A Meta-Analysis. Cancers 2025, 17, 862".

    Cancers·2026

    Selection Criteria for De-Escalated Chemoradiotherapy for HPV-Related Oropharyngeal Cancer Based on Prognostic Biomarkers or Early Tumor Response to Therapy: A Narrative Review.

    Diagnostics (Basel, Switzerland)·2026

    Quantitative Imaging Advances in HPV-Positive Oropharyngeal Carcinoma.

    Cancers·2026

    Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios Predict Improved Survival and Response to Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of the Larynx.

    Head & neck·2025

    The Value of Circulating Tumor HPV DNA in Head and Neck Squamous Cell Cancer: A Review.

    Diagnostics (Basel, Switzerland)·2025

    Exploring the landscape of targetable alterations in patients with glioblastoma.

    Nature reviews. Clinical oncology·2026

    AI-based augmentation of oncology clinical trials.

    Nature reviews. Clinical oncology·2026

    Clinical toxicity of ADCs and ICI-ADC combinations: mechanisms, patterns and management.

    Nature reviews. Clinical oncology·2026

    De-escalation trials in multiple myeloma: past, present and future.

    Nature reviews. Clinical oncology·2026

    Towards liquid biopsy-based analysis of antitumour immunity.

    Nature reviews. Clinical oncology·2026

    CRISPR in clinical oncology: translational advances from molecular diagnostics to therapeutics.

    Nature reviews. Clinical oncology·2026

    Transmurality and Autonomic Effects of Pulsed Field Ablation on the Mitral Isthmus.

    Circulation. Arrhythmia and electrophysiology·2026

    Ultra-broadband Epsilon-Near-Zero Ultrathin Metafilms Assembled by 2D Nanosheets Overcoming Size Limitation in Metamaterials.

    Advanced materials (Deerfield Beach, Fla.)·2026

    Surface Neuronal-Like Structuring of High-Strength CFRP for Enhanced Electromagnetic Interference Shielding.

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

    Dimensional Engineering of Carbon-Based Hybrids: From 1D Conductive Networks to 3D Porous Architectures for Next-Generation Microwave Absorption.

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

    Ephaptic coupling improves the neural population code.

    bioRxiv : the preprint server for biology·2026

    Peripheral Nerve Stimulation Optimized Pulses for EPI (POPE) allows high-resolution fMRI.

    bioRxiv : the preprint server for biology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us